Trials / Active Not Recruiting
Active Not RecruitingNCT04616144
Fresh Corneal Lenticule Implantation in Hyperopic Patients With High Astigmatism
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 55 (estimated)
- Sponsor
- Eye Hospital Pristina Kosovo · Academic / Other
- Sex
- All
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The refractive combination of high hyperopia with high astigmatism is difficult to treat surgically. In addition, there are not many suitable options to offer such patients presenting with this condition. The method used at the EYE Hospital Pristina using fresh lenticule implantation by ReLex-SMILE is safe and effective method. Fresh Corneal Implantation is a safe treatment for hyperopia with high astigmatism comparing with refractive IOL implantation (loss of accommodation, endophthalmitis). Its primary objective is to increase visual acuity, accommodation process, patient satisfaction which makes patient to enjoy a happier life. We believe this study will be the future of refractive surgery for treating high hyperopia.
Detailed description
This study is to investigate the effect of fresh corneal lenticule implantation as allogenic implant that will be taken from myopic patients to implant in hyperopic patients with high astigmatism using VisuMax Femtosecond laser - Smile module surgery with primary objective to assess (increase) visual acuity (far, intermediate, near vision) and secondary objective to stabilize (decrease) high astigmatism by reducing K-values.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Fresh Corneal Lenticule Implantation using Relex-Smile VisuMax Femtosecond Laser | Fresh Corneal Lenticule Implantation using ReLex-Smile |
Timeline
- Start date
- 2019-05-01
- Primary completion
- 2020-05-01
- Completion
- 2026-05-01
- First posted
- 2020-11-04
- Last updated
- 2024-08-27
Locations
1 site across 1 country: Kosovo
Source: ClinicalTrials.gov record NCT04616144. Inclusion in this directory is not an endorsement.